$80.28
-6.48-7.47%
Last update: Nov 5, 4:00 PM
Inhibrx Biosciences Inc
INBXNASDAQ
The average analyst price target for Inhibrx Biosciences is $197.50, 146.0% above the current price. Of 4 analysts, 2 rate it Buy and 2 Hold. Targets range from $150 to $245. The latest change came on Aug 24, 2026, when HC Wainwright & Co. initiated coverage of Inhibrx Biosciences with a Buy rating and a $245 price target.
Price Target Range — 3 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
